- Report
- August 2023
- 295 Pages
Global
From €9149EUR$9,500USD£7,868GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2648EUR$2,750USD£2,278GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
Mercaptopurine is a drug used to treat gastrointestinal diseases, such as Crohn's disease and ulcerative colitis. It is an immunosuppressant, meaning it reduces the body's immune response, which can help reduce inflammation in the gastrointestinal tract. Mercaptopurine is usually taken orally, but can also be administered intravenously. It is often used in combination with other drugs, such as corticosteroids, to maximize its effectiveness.
Mercaptopurine is available in both generic and brand-name forms, and is sold by a variety of pharmaceutical companies. Some of the companies that produce and market mercaptopurine include AbbVie, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more